Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

E-Therapeutics PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 Jul 2016 Reuters Investment Profile 12 $20.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics Plc (e-Therapeutics) is a drug...

05 Jul 2016 GlobalData 38 $300.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics Plc (e-Therapeutics) is a drug...

07 Jun 2016 GlobalData 38 $300.00

E-THERAPEUTICS - COURTING COMMERCIALISATION PARTNERS

e-Therapeutics’ strategy has evolved, shifting from investment into its proprietary discovery platform to commercialisation o...

19 May 2016 Edison Investment Research 12 $10.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

04 Mar 2016 GlobalData 47 $300.00

E-THERAPEUTICS - LIGHT AT THE END OF THE FUNNEL

e-Therapeutics’ (ETX) share price fell c 30% on news that the ETS6103 Phase IIb trial as a second-line therapy for major depr...

18 Feb 2016 Edison Investment Research 3 $10.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

03 Dec 2015 GlobalData 51 $300.00

E-THERAPEUTICS – DISCOVERY PLATFORM COMING TO THE FORE

e-Therapeutics' lead assets, ETS2101 (cancer) and ETS6103 (major depressive disorders), are progressing through clinical tria...

12 Oct 2015 Edison Investment Research 6 $10.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

14 Sep 2015 GlobalData 53 $125.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

16 Jun 2015 GlobalData 53 $125.00